In the treatment of lung cancer, except for surgery, one of the most effective methods is chemotherapy. The main role of chemotherapy drugs is to control the growth of lung tumors, delay the spread and reduce the probability of metastasis. However, chemotherapy drugs while killing lung cancer cells can also damage normal functional cells. It leads to many toxic reactions and adverse reactions.
Immune enhancers in the treatment of lung cancer enhance the removal of lung cancer cells, improve the efficacy. Mushroom polysaccharide is the important active substances in mushrooms. It has immunity enhancement and anti-tumor activity. The main ingredient of mushroom polysaccharides is Mannose Glutathione. It belongs to the typical T cell activator which improves the activity of NK cells and the antibody-dependent cytotoxicity. Experiments show that mushroom polysaccharides can improve the drug resistance of chemotherapeutic drugs and anti-tumor efficacy. Not only can it improve the quality of patients’ life, but also improve the sensitivity to chemotherapy drugs for lung cancer.
In recent years, the adjuvant therapy of mushroom polysaccharides on malignancy treatment effect has been increasingly recognized. For the treatment of gastric cancer, esophageal cancer, and colorectal cancer, mushroom polysaccharides are cause for concern by clinicians. There is still a great research prospect of it and it is worthy of exploration.
